机译:BRAF BRAF V600E V600E V600E V600E V600E V600E突变修复/熟练不匹配修复,转移性结直肠癌:287例患者的多中心系列
Medical Oncology Department Centre Leon Berard Lyon I UniversityLyon France;
Medical Oncology Department AP‐HP Saint‐Antoine Hospital Sorbonne UniversityParis France;
Gastrointestinal Oncology Unit Department of Cancer Medicine Gustave RoussyVillejuif France;
Department of Medical Oncology University Hospital Toulouse Paul Sabatier UniversityToulouse;
Department of Medical Oncology Eugène Marquis Cancer InstituteRennes France;
Gastroenterology Department Rennes University Hospital Rennes 1 UniversityRennes France;
Medical Oncology Department Institut Curie René Huguenin HospitalSaint‐Cloud France;
Gastrointestinal Oncology Jean‐Mermoz HospitalLyon France;
Gastroenterology Department Antoine Lacassagne Cancer CentreNice France;
Medical Oncology Department Paoli‐Calmettes Institute Aix‐Marseille UniversityMarseille France;
Digestive Oncology Department Montpellier Cancer InstituteMontpellier France;
Department of Gastroenterology and Digestive Oncology European Georges Pompidou Hospital;
Department of Digestive Oncology Amiens University HospitalAmiens France;
Department of Oncology Henri Mondor HospitalAP‐HP Créteil France;
René Gauducheau West Cancer InstituteSaint‐Herblain France;
Gastrointestinal Oncology Unit CHU Cochin‐Port‐RoyalParis France;
Gastrointestinal Oncology Unit Department of Cancer Medicine Gustave RoussyVillejuif France;
Medical Oncology Department Centre Leon Berard Lyon I UniversityLyon France;
Clinical Research and Innovation Department Leon Berard Cancer CentreLyon France;
Department of Gastroenterology Poitiers University HospitalPoitiers France;
Colorectal cancer; BRAF; Mismatch repair testing; Prognostic; Decision making;
机译:BRAF BRAF V600E V600E V600E V600E V600E V600E突变修复/熟练不匹配修复,转移性结直肠癌:287例患者的多中心系列
机译:老年大肠癌患者中错配修复表型和V600E BRAF突变的高患病率
机译:不匹配修复(MMR)基因改变和BRAF V600E突变是MMR缺乏结直肠癌中免疫检查点抑制剂的潜在预测生物标志物
机译:使用无标记微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRA,BRAF,PIK3CA突变
机译:使用癌症的基因工程小鼠模型进行BRAF(V600E)诱导的非小细胞肺癌的遗传合作。
机译:BRAFV600E突变错配修复不足/错配修复充分转移性结直肠癌的特征:多中心研究共287例患者
机译:BRAF V600E突变特性,缺陷不匹配修复/蓬密匹配修复,转移性结直肠癌:一系列287例患者